115 related articles for article (PubMed ID: 14732363)
1. Potential role for antiangiogenic proteins in the myocardial infarction repair process.
Thompson JL; Ryan JA; Barr ML; Franc B; Starnes VA; Schwarz MA
J Surg Res; 2004 Jan; 116(1):156-64. PubMed ID: 14732363
[TBL] [Abstract][Full Text] [Related]
2. Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia.
Quintos-Alagheband ML; White CW; Schwarz MA
Antioxid Redox Signal; 2004 Feb; 6(1):137-45. PubMed ID: 14713345
[TBL] [Abstract][Full Text] [Related]
3. Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis.
Yuan C; Yan L; Solanki P; Vatner SF; Vatner DE; Schwarz MA
J Mol Cell Cardiol; 2015 Feb; 79():224-31. PubMed ID: 25456857
[TBL] [Abstract][Full Text] [Related]
4. EMAP II: a modulator of neovascularization in the developing lung.
Schwarz M; Lee M; Zhang F; Zhao J; Jin Y; Smith S; Bhuva J; Stern D; Warburton D; Starnes V
Am J Physiol; 1999 Feb; 276(2):L365-75. PubMed ID: 9950900
[TBL] [Abstract][Full Text] [Related]
5. Temporo-spatial distribution of endothelial-monocyte activating polypeptide II, an anti-angiogenic protein, in the mouse embryo.
Zhang F; Schwarz MA
Dev Dyn; 2000 Jul; 218(3):490-8. PubMed ID: 10878614
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of endothelial monocyte-activating polypeptide-II in acute lung inflammation.
Journeay WS; Janardhan KS; Singh B
Inflamm Res; 2007 May; 56(5):175-81. PubMed ID: 17393072
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.
Murray JC; Barnett G; Tas M; Jakobsen A; Brown J; Powe D; Clelland C
Am J Pathol; 2000 Dec; 157(6):2045-53. PubMed ID: 11106577
[TBL] [Abstract][Full Text] [Related]
8. Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma.
Lans TE; ten Hagen TL; van Horssen R; Wu PC; van Tiel ST; Libutti SK; Alexander HR; Eggermont AM
Ann Surg Oncol; 2002 Oct; 9(8):812-9. PubMed ID: 12374666
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II.
Schwarz MA; Thornton J; Xu H; Awasthi N; Schwarz RE
PLoS One; 2012; 7(3):e33101. PubMed ID: 22412987
[TBL] [Abstract][Full Text] [Related]
11. Regulation of EMAP II by hypoxia.
Matschurat S; Knies UE; Person V; Fink L; Stoelcker B; Ebenebe C; Behrensdorf HA; Schaper J; Clauss M
Am J Pathol; 2003 Jan; 162(1):93-103. PubMed ID: 12507893
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH.
Chang SY; Ko HJ; Heo TH; Kang CY
Mol Pharmacol; 2005 May; 67(5):1534-43. PubMed ID: 15710745
[TBL] [Abstract][Full Text] [Related]
13. Expression of EMAP II in the developing and adult mouse.
Knies UE; Kröger S; Clauss M
Apoptosis; 2000 Apr; 5(2):141-51. PubMed ID: 11232242
[TBL] [Abstract][Full Text] [Related]
14. Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of the proteasome.
Tandle AT; Calvani M; Uranchimeg B; Zahavi D; Melillo G; Libutti SK
Exp Cell Res; 2009 Jul; 315(11):1850-9. PubMed ID: 19362550
[TBL] [Abstract][Full Text] [Related]
15. Lesional expression of a proinflammatory and antiangiogenic cytokine EMAP II confined to endothelium and microglia/macrophages during secondary damage following experimental traumatic brain injury.
Mueller CA; Schluesener HJ; Conrad S; Meyermann R; Schwab JM
J Neuroimmunol; 2003 Feb; 135(1-2):1-9. PubMed ID: 12576219
[TBL] [Abstract][Full Text] [Related]
16. Spinal cord injury induces lesional expression of the proinflammatory and antiangiogenic cytokine EMAP II.
Mueller CA; Schluesener HJ; Conrad S; Meyermann R; Schwab JM
J Neurotrauma; 2003 Oct; 20(10):1007-15. PubMed ID: 14588117
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of endothelial monocyte-activating polypeptide II in the human endometrium across the menstrual cycle: regulation of expression by prostaglandin E(2).
Battersby S; Boddy SC; Critchley HO; Jabbour HN
J Clin Endocrinol Metab; 2002 Aug; 87(8):3928-35. PubMed ID: 12161535
[TBL] [Abstract][Full Text] [Related]
18. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells.
Schluesener HJ; Seid K; Zhao Y; Meyermann R
Glia; 1997 Aug; 20(4):365-72. PubMed ID: 9262239
[TBL] [Abstract][Full Text] [Related]
19. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
Xie H; Xue YX; Liu LB; Liu YH
Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
[TBL] [Abstract][Full Text] [Related]
20. The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.
Xu H; Malinin NL; Awasthi N; Schwarz RE; Schwarz MA
J Biol Chem; 2015 Apr; 290(15):9753-66. PubMed ID: 25724651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
